Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
about
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Structural damage progression ...... in the phase 3 RA-BEGIN study
@en
Structural damage progression ...... in the phase 3 RA-BEGIN study
@nl
type
label
Structural damage progression ...... in the phase 3 RA-BEGIN study
@en
Structural damage progression ...... in the phase 3 RA-BEGIN study
@nl
prefLabel
Structural damage progression ...... in the phase 3 RA-BEGIN study
@en
Structural damage progression ...... in the phase 3 RA-BEGIN study
@nl
P2093
P2860
P1476
Structural damage progression ...... in the phase 3 RA-BEGIN study
@en
P2093
Douglas Schlichting
Eric Nantz
Esperanza Naredo
Francesco De Leonardis
Gabriella Meszaros
Inmaculada de la Torre
Mikkel Østergaard
Patrick Durez
Pedro López-Romero
Roy Fleischmann
P2860
P304
P356
10.1007/S10067-018-4221-0
P407
P577
2018-09-01T00:00:00Z